[Federal Register Volume 62, Number 33 (Wednesday, February 19, 1997)] [Notices] [Pages 7468-7469] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 97-3956] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Center for Substance Abuse Prevention; Notice of Meeting Pursuant to Public Law 92-463, notice is hereby given of the meeting of the Drug Testing Advisory Board of the Center for Substance Abuse Prevention in April 1997. The Drug Testing Advisory Board (DTAB) is having a 3-day scientific meeting to discuss drug testing alternative specimens and technologies as they apply to workplace drug testing programs. The entire meeting is open to the public; however, attendance by the public will be limited to space available. The first two days will consist of presentations on the principles and criteria of workplace drug testing program requirements and industry representatives discussing alternative specimens/technologies (urine, hair, saliva, sweat, and non-instrument based on-site tests). The presentations will be focused on the following areas for each alternative specimen/technology: specimen collection and chain of custody, initial test reagents and procedures, confirmatory test procedures, internal quality control program, reporting test results, interpreting test results, and an external quality assurance program. On the third day, the DTAB will review the presentations, identify areas of concern, and make recommendations concerning those specimens/technologies for workplace drug testing. Interested persons may present information or views, orally or in writing, on these issues pending before the Board. Those desiring to make formal presentations should notify the contact person before March 7. A coordinator for each alternative specimen/technology will select the presenters. The presenters who will discuss the underlying principles and [[Page 7469]] criteria for each major topic are required to submit their presentations in writing at least four weeks before the meeting. These will be shared with all presenters at least 3 weeks before the meeting. The presenters describing how each type of specimen and/or technology satisfies, or does not satisfy, the requirements (each presentation is limited to 15 minutes) are required to submit their presentations in written form at least two weeks before the meeting. These will be shared with all presenters. An agenda for this meeting and a roster of board members may be obtained from: Ms. Giselle Hersh, Division of Workplace Programs, Room 13A-54, 5600 Fishers Lane, Rockville, MD 20857, Telephone: (301) 443- 6014. Substantive program information may be obtained from the contact whose name and telephone number is listed below. Committee Name: Drug Testing Advisory Board. Meeting Date: April 28-30, 1997. Place: DoubleTree Hotel, 1750 Rockville Pike, Rockville, Maryland 20852. Open: April 28-30, 1997, 8:30 a.m.-5:00 p.m. Contact: Donna M. Bush, Ph.D.; Executive Secretary, Telephone: (301) 443-6014 and FAX: (301) 443-3031. Dated: February 12, 1997. Jeri Lipov, Committee Management Officer, SAMHSA. [FR Doc. 97-3956 Filed 2-18-97; 8:45 am] BILLING CODE 4162-20-P